Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Open-market buy Chief Medical Officer bought 4,000 shares at $14.15 ($56,600)
  2. 4 Open-market buy Director bought 35,000 shares at $14.07 ($492,527)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale Director sold 1,000,000 shares at $17.00 ($17,000,000)
  6. 4 Open-market sale Chief Operating Officer sold 1,000 shares at $26.41 ($26,410)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $19.20 ($57,600)
  11. 4 Open-market sale Chief Operating Officer sold 6,000 shares at an average $20.58 ($123,484)
  12. 4 Open-market sale Chief Financial Officer sold 15,000 shares at $19.20 ($288,000)
  13. 4 Open-market sale Director sold 75,000 shares at $15.82 ($1,186,500)
  14. 4 Open-market sale 10% owner sold 75,000 shares at $15.82 ($1,186,500)
  15. 4 Open-market sale 10% owner sold 130,000 shares at an average $15.79 ($2,052,700)
  16. 4 Open-market sale Director sold 130,000 shares at an average $15.79 ($2,052,700)
  17. 4 Open-market sale 10% owner sold 21,480 shares at $15.71 ($337,451)
  18. 4 Open-market sale Director sold 21,480 shares at $15.71 ($337,451)
  19. 4 Open-market sale 10% owner sold 12,819 shares at $15.77 ($202,156)
  20. 4 Open-market sale Director sold 12,819 shares at $15.77 ($202,156)

Page 15 of 18 · 351 filings